Reaction
Urinary Tract Infection Enterococcal reporting signals
As of the last recalculation, Urinary Tract Infection Enterococcal appears in 929 FAERS reports alongside 34 co-occurring drug terms. The strongest observed disproportionality signal is ANTI-THYMOCYTE GLOBULIN (RABBIT) (PRR 51.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Anti-Thymocyte Globulin (Rabbit) | 18 | 51.0 | 51.1 |
| Basiliximab | 24 | 46.9 | 47.0 |
| Amphotericin B | 16 | 29.1 | 29.1 |
| Piperacillin Sodium,Tazobactam Sodium | 33 | 28.9 | 28.9 |
| Piperacillin And Tazobactam | 16 | 28.5 | 28.5 |
| Valganciclovir Hydrochloride Powder, | 14 | 26.1 | 26.1 |
| Valganciclovir | 21 | 25.5 | 25.5 |
| Valganciclovir Hydrochloride | 21 | 25.5 | 25.5 |
| Linezolid | 32 | 24.9 | 24.9 |
| Meropenem | 33 | 23.9 | 23.9 |
| Polyethylene Glycol | 11 | 23.0 | 23.1 |
| Gentamicin | 13 | 22.6 | 22.6 |
| Piperacillin Sodium And Tazobactam Sodium | 18 | 20.9 | 21.0 |
| Mycophenolate Mofetil | 112 | 20.9 | 20.9 |
| Mycophenolate Mofetil Hydrochloride | 112 | 20.8 | 20.9 |
| Gentamicin Sulfate | 13 | 18.7 | 18.7 |
| Daspone | 8 | 18.6 | 18.6 |
| Dapsone Gel, 5% | 8 | 18.5 | 18.6 |
| Axicabtagene Ciloleucel | 8 | 18.3 | 18.3 |
| Heparin Sodium | 11 | 18.1 | 18.1 |
| Tacrolimus | 112 | 18.1 | 18.1 |
| Dapsone | 8 | 16.9 | 16.9 |
| Sirolimus | 10 | 16.8 | 16.8 |
| Atovaquone | 6 | 16.8 | 16.8 |
| Tacrolimus Ointment 0.1% | 84 | 16.5 | 16.5 |
| Tacrolimus Extended-Release Capsules | 84 | 16.5 | 16.5 |
| Cefepime | 10 | 15.8 | 15.8 |
| Cefepime Hydrochloride | 10 | 14.0 | 14.1 |
| Pemetrexed | 13 | 13.8 | 13.8 |
| Azacitidine | 12 | 9.2 | 9.2 |
| Azacitidine For | 7 | 8.7 | 8.7 |
| Gemcitabine Hydrochloride | 20 | 8.6 | 8.6 |
| Dalfampridine | 24 | 7.7 | 7.7 |
| Droxidopa | 5 | 5.2 | 5.2 |